Search Results1-20 of  83

  • 1 / 5
  • INABA MASAAKI ID: 9000001326873

    Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine (2004 from CiNii)

    Articles in CiNii:1

    • Secondary osteoporosis : thyrotoxicosis, rheumatoid arthritis, and diabetes mellitus (2004)
  • INABA MASAAKI ID: 9000001920274

    Department of Psychiatry, Ozone Hospital (2002 from CiNii)

    Articles in CiNii:1

    • Monozygotic twin cases of the agenesis of the corpus callosum with schizophrenic disorder (2002)
  • INABA MASAAKI ID: 9000020685843

    Second Department of Internal Medicine, Osaka City University Medical School (1986 from CiNii)

    Articles in CiNii:1

    • A case of normocalcemic primary hyperparathyroidism with osteomalacia. (1986)
  • INABA MASAAKI ID: 9000020686170

    Second Department of Internal Medicine Osaka City University Medical School (1987 from CiNii)

    Articles in CiNii:1

    • A case of Hyponatremia in Panhypopituitarism Caused by the Primary Empty Sella Syndrome (1987)
  • INABA MASAAKI ID: 9000020687766

    The Second Departments of Internal Medicine, Osaka City University Medical School (1984 from CiNii)

    Articles in CiNii:1

    • Tissue calmodulin levels in normal and Graves' thyroids. (1984)
  • INABA MASAAKI ID: 9000020809254

    Second Department of Internal Medicine, Osaka City University (1982 from CiNii)

    Articles in CiNii:1

    • A case report on disequilibrium hypercalcemia in hyperthyroidism. Comparison of calcium metabolism with other patients with hyperthyroidism.:Comparison of Calcium Metabolism with Other Patients with Hyperthyroidism (1982)
  • INABA MASAAKI ID: 9000252824862

    Second Department of Internal Medicine, Osaka City University Medical School (1999 from CiNii)

    Articles in CiNii:1

    • Synergistic Enhancement by 12-O-Tetradecanoylphorbol- 13-acetate and Dibutyryl cAM P of 1.ALPHA.,25-Dihydroxyvitamin D3 Action in Human Promyelocytic Leukemic HL-60 Cells. (1999)
  • INABA MASAAKI ID: 9000379605804

    Chubu University (2018 from CiNii)

    Articles in CiNii:1

    • P-23 Improvement of the Bioethanol Process (2018)
  • INABA Masaaki ID: 9000000006276

    Toshiba Corporation (1995 from CiNii)

    Articles in CiNii:2

    • Development of Large-Capacity Gas-Insulated Transformer (1995)
    • Size Reduction and Nonflammability of Substation Equipment (1993)
  • INABA Masaaki ID: 9000000164011

    Tohoku University (1998 from CiNii)

    Articles in CiNii:2

    • Modelless Multiple Control Systems Switched by Robust Performance Criteria Concerned with Stability and Responsiveness (1997)
    • A Proposal of Multiple Control System based on Real-Time Trial Control and Its Application to Antiskid Braking System (1998)
  • INABA Masaaki ID: 9000000580982

    Second Division of Surgery, Kanagawa Cancer Center (2000 from CiNii)

    Articles in CiNii:1

    • Significance of the Parathyroid Hormone-related Protein Expression in Breast Carcinoma (2000)
  • INABA Masaaki ID: 9000001413531

    Department of Surgery, Breast and Thyroid Division, Kanagawa Cancer Center (2004 from CiNii)

    Articles in CiNii:1

    • A Multicenter Phase II Study of Docetaxel 60mg/m^2 as First-Line Chemotherapy in Patients with Advanced or Recurrent Breast Cancer (2004)
  • INABA Masaaki ID: 9000001782999

    Division of Breast and Thyroid Surgery, Kanagawa Cancer Center (2005 from CiNii)

    Articles in CiNii:1

    • Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsy (2005)
  • INABA Masaaki ID: 9000002024902

    Kobayashi Engineering Works, Ltd. (2007 from CiNii)

    Articles in CiNii:1

    • Octopus Stock Approach System (2007)
  • INABA Masaaki ID: 9000002941817

    Articles in CiNii:27

    • ANALYSES OF PLASMA METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASES IN PATIENTS WITH BREAST CANCER (1998)
    • THE EFFECT OF PRIMARY SYSTEMIC THERAPY ON ESTROGEN AND PROGESTERONE RECEPTOR EXPRESSION AND HER2 STATUS IN BREAST CANCER (2009)
    • Outcome of surgical treatment in papillary thyroid carcinoma and risk classification : A study of using AMES risk criteria (2006)
  • INABA Masaaki ID: 9000004081001

    Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University, Graduate School of Medicine (2012 from CiNii)

    Articles in CiNii:154

    • Remission of Insulin Autoimmune Syndrome in a Patient with Grave's Disease by Treatment with Methimazole (1999)
    • Synergistic Enhancement by 12-O-Tetradecanoylphorbol-13-acetate and Dibutyryl cAMP of 1α, 25-Dihydroxyvitamin D_3 Actionin Human Promyelocytic Leukemic HL-60 Cells (1999)
    • A Case of Renin-Producing Adrenocortical Cancer (2000)
  • INABA Masaaki ID: 9000018700725

    Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine (2011 from CiNii)

    Articles in CiNii:1

    • Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy : evaluation of both HBsAg-positive and HBsAg-negative cohorts (2011)
  • INABA Masaaki ID: 9000019241444

    Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine (2011 from CiNii)

    Articles in CiNii:1

    • Enhanced Urinary Bladder, Liver and Colon Carcinogenesis in Zucker Diabetic Fatty Rats in a Multiorgan Carcinogenesis Bioassay : Evidence for Mechanisms Involving Activation of PI3K Signaling and Impairment of p53 on Urinary Bladder Carcinogenesis (2011)
  • INABA Masaaki ID: 9000022201609

    Second Department of Internal Medicine, Osaka City University Medical School (1991 from CiNii)

    Articles in CiNii:1

    • Effects of Uremic Serum on 1, 25-Dihydroxyvitamin D<sub>3</sub>-Induced Differentiation of a Human Promyelocytic Leukemia Cell Line, HL-60 (1991)
  • INABA Masaaki ID: 9000242116659

    Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine (2012 from CiNii)

    Articles in CiNii:1

    • TRAIL is not associated with endothelial and vascular smooth muscle dysfunction in patients with type 2 diabetes mellitus (2012)
  • 1 / 5
Page Top